- Alopecia(Cosmetics 1)
- Alopecia(Cosmetics 2)
- Alopecia(Drug)
- Arthritis
- NASH
- Psoriasis
- IBD
- Me Ture
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
-
- 1Q
- 2Q
- 3Q
- 4Q
Screening of Natural sources
DEE
Process develop.
Process develop.
Formulation Study
Clinical Trials
Laun-
ching
ching
POC
Efficacy Study
Fomulation & Analysis Study
Manufacturing & Stability
Clinical Trials
Laun-
ching
ching
Marker & Active Substance ID
Nonclinical Study, CMC
P1(Topical)
P2(Topical)
P3(Topical)
NDA
Launching
Nonclinical Study, CMC
P1(Oral)
P2(Oral)
P3(Oral)
NDA
Pricing
Laun-
ching
ching
Nonclinical Study
P3(Oral)
P3(Oral)
Nonclinical Study
P2(Oral)
P3(Oral)
Nonclinical Study
P2(Oral)